Fortaz® demonstrou eficácia clínica de 94% e bacteriológica de 68% quando utilizado em pacientes com sepsis bacteriana. FANG, CT. et al. Safety and efficacy of cefpirome in comparison with ceftazidime in Chinese patients with sepsis due to bacterial infections. Chemotherapy, 46(5): 371-378, 2000.